Health & Tech

Mindset Pharma to be Acquired by Otsuka Pharmaceutical

Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) announced that they have entered into a definitive arrangement agreement (the "Agreement") pursuant…

August 31, 2023

Capital 10X Interview Series | Mindset Pharma: Leaders in Next-Gen Psychedelics

Mindset Pharma: Leaders in Next-Gen Psychedelics We had the pleasure of sitting down with James Lanthier, CEO of Mindset Pharma…

July 11, 2023

Mindset Pharma: New Study Supports Non-Hallucinogenic Psychedelics

Recently, Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) a drug discovery company specializing in next-generation psychedelics, announced the filing of…

June 15, 2023

Mindset Pharma Files Two Patent Applications for its Non-Hallucinogenic Non-Tryptamine Compounds

Mindset Pharma Inc. (CSE: MSET) (OTCQB: MSSTF) a drug discovery company developing novel, optimized, next-generation psychedelic and non-psychedelic medications to…

April 27, 2023

Ricebran Technologies (RIBT) – Expansion and Grain Industry Tailwinds

Ricebran Technologies Inc. (NASDAQ: RIBT) is a special ingredients company producing food products derived mainly from rice, stabilized rice bran…

May 25, 2022

Capital 10X Growth Navigator – February 1st 2022

Cannabis Verano Acquires Goodness Growth Consolidation in the cannabis sector continues, Verano (CSE:VRNO) announced today a proposed acquisition of Goodness…

February 1, 2022

Growth Navigator: Psilocybin Exports, Cannabis ESG & SAFE

PSYCHEDELICS Atai Life Sciences Increases It's Stake in Compass Pathways Atai Life Sciences (Nasdaq: ATAI) announced that it has increased…

December 2, 2021

Growth Navigator: Cannabis, Copper & Psychedelics

Cannabis Stocks Come Back to Life It's been a very volatile year for the cannabis sector. The Horizons Marijuana Life…

November 17, 2021

Pfizer Takes the Lead, as the World Moves Closer to A Viable Vaccine

On November 9th, Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2…

November 11, 2020

Johnson & Johnson pushes the Pause Button on its COVID-19 Clinical Trial

Johnson & Johnson (NYSE: JNJ) reported its earnings on Oct 13th; but the news that captured headlines was that the…

October 14, 2020